MedPath

Evaluation of cinacalcet on clinical outcome depending on serum PTH level in Japanese patients with SHPT:ECO study

Not Applicable
Conditions
Secondary hyperparathyroidism
Registration Number
JPRN-UMIN000002769
Lead Sponsor
Division of Kidney and Hypertension, Department of Internal Medicine,The Jikei University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

1. pregnant woman 2.received therapy with bisphosphonate within 24 weeks before IC 3.received therapy with estrogen hormone when signed IC 4.severe hepatic dysfunction or cirrhosis 5. drug allergies 6. malignancy 7. unsuitable patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the proportion of patients who achieve JSDT guideline targets
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath